HILL MATTHEW C 4

What Happened

• Matthew C. Hill, Chief Financial Officer of Apyx Medical Corp (APYX), received a derivative award: a grant of stock options covering 132,066 shares reported on a Form 4 dated 2026-06-15 for a 2026-06-11 grant. The Form 4 shows an acquisition price of $0 (typical for option grants as reported) and the award vests ratably over 36 months, becoming fully vested on the third anniversary of the grant.

Key Details

• Transaction date: 2026-06-11 (reported on Form 4 filed 2026-06-15)
• Transaction type: A = Award/Grant (derivative option award)
• Shares/options granted: 132,066
• Reported acquisition price: $0 (as shown on Form 4)
• Vesting: Ratably over 36 months; fully vested on the third anniversary (see footnote F1)
• Shares owned after transaction: Not specified in the filing
• Timeliness: Filing dated 2026-06-15 for a 2026-06-11 grant appears to be within the standard two-business-day Form 4 filing window

Context

• This is a compensation-related option grant (not an open-market purchase or sale). No exercise or sale occurred at the time of this filing. Options typically require a future exercise (and payment of the exercise price) to convert to shares; the Form 4 reports the grant as a derivative award. This filing reports the grant details but does not indicate any immediate cash transaction or sale.